The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors. This research was sponsored by the American Head and Neck Society (AHNS) Education Committee and funded by the University of Pennsylvania Robert Wood Johnson Foundation Clinical Scholars Program.
The authors wish to acknowledge Alan Shi and Jordyn Feingold for their contributions to survey administration and manuscript preparation.
American Society of Clinical Oncology. 10 Things Physicians and Patients Should Question. Choosing WiselyWeb site. Available at: http://www.choosingwisely.org/doctor-patient-lists/american-society-of-clinical-oncology/. Accessed December 12 2014.
GrunfeldEHodgsonDCDel GiudiceMEMoineddinR. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract2010;6:174–181.
SalloumRGHornbrookMCFishmanPA. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer2012;118:5644–5651.
PotoskyALHanPKRowlandJ. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med2011;26:1403–1410.
HanPKKlabundeCNNooneAM. Physicians’ beliefs about breast cancer surveillance testing are consistent with test overuse. Med Care2013;51:315–323.
MyssiorekDRomanBWangM. Trends in utilization of FDG PET imaging in the American Head and Neck Society. Presented at the American Head and Neck Society 2009 Annual Meeting; May 30–31, 2009; Phoenix, Arizona.
CabanaMDRandCSPoweNR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA1999;282:1458–1465.
EspelandABaerheimA. Factors affecting general practitioners’ decisions about plain radiography for back pain: implications for classification of guideline barriers—a qualitative study. BMC Health Serv Res2003;3:8.
HarrisPATaylorRThielkeR. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform2009;42:377–381.
JagsiRHuangGGriffithK. Attitudes toward and use of cancer management guidelines in a national sample of medical oncologists and surgeons. J Natl Compr Canc Netw2014;12:204–212.
KerfootBPHolmbergEFLawlerEV. Practitioner-level determinants of inappropriate prostate-specific antigen screening. Arch Intern Med2007;167:1367–1372.
OngSCSchöderHLeeNY. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med2008;49:532–540.
GourinCGBoyceBJWilliamsHT. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope2009;119:2150–2155.
KaoJVuHLGendenEM. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer2009;115:4586–4594.
SherDJTishlerRBAnninoDPungliaRS. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol2010;21:1072–1077.
PryorDIPorcedduSVScuffhamPA. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma. Head Neck2013;35:1287–1294.
LoweVJBoydJHDunphyFR. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol2000;18:651–658.
LeeJCKimJSLeeJH. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol2007;43:686–692.
PerieSHugentoblerASusiniB. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg2007;137:647–653.
SalaunPYAbgralRQuerellouS. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?Head Neck2007;29:1115–1120.
AbgralRQuerellouSPotardG. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?J Nucl Med2009;50:24–29.
KrabbeCaPruimJDijkstraPU. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med2009;50:1940–1947.
BeswickDMGoodingWEJohnsonJTBranstetterBF. Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring. Laryngoscope2012;122:1512–1517.
DunskyKAWehrmannDJOsmanMM. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. Laryngoscope2013;123:2161–2164.
KostakogluLFardaneshRPosnerM. Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck. Oncologist2013;18:1108–1117.
McDermottMHughesMRathT. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer. AJNR Am J Neuroradiol2013;34:1632–1636.
SpectorMEChinnSBRoskoAJ. Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy?Laryngoscope2012;122:1507–1511.
HoASTsaoGJChenFW. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer2013;119:1349–1356.
ZafereoMEHanasonoMMRosenthalDI. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer2009;115:5723–5733.
GoodwinWJJr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?Laryngoscope2000;110(3 Pt 2 Suppl 93):1–18.
LockerGYHamiltonSHarrisJ. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol2006;24:5313–5327.
FigueredoARumbleRBMarounJ. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer2003;3:26.
Rodriguez-MorantaFSaloJArcusaA. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol2006;24:386–393.
JefferyMHickeyBEHiderPN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev2007:CD002200.
LuWLJansenLPostWJ. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat2009;114:403–412.
Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA1994;271:1587–1592.
Rosselli Del TurcoMPalliDCariddiA. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA1994;271:1593–1597.
PalliDRussoASaievaC. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA1999;281:1586.
MeierJDOliverDAVarvaresMA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck2005;27:952–958.
JohnsonFEJohnsonMHClementeMF. Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer. Ann Surg Oncol2006;13:1063–1071.
WuAWWangMBNguyenCT. Surgical practice patterns in the treatment of papillary thyroid microcarcinoma. Arch Otolaryngol Head Neck Surg2010;136:1182–1190.
MalloyKMEllenderSMGoldenbergDDolanRW. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons. JAMA Otolaryngol Head Neck Surg2013;139:1037–1042.
MakkiFMWilliamsBRajaramanM. Current practice patterns in the management of glottic cancer in Canada: results of a national survey. J Otolaryngol Head Neck Surg2011;40:205–210.
PeabodyJWLuckJGlassmanP. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA2000;283:1715–1722.
PeabodyJWLuckJGlassmanP. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med2004;141:771–780.
TunisSWhicherD. The National Oncologic PET Registry: lessons learned for coverage with evidence development. J Am Coll Radiol2009;6:360–365.